NCT07896811
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07896811
Title Triplet Immunotherapy For Exhausted Cell Targets in Advanced Squamous Cell Carcinoma (TRIFECTA-SCC)
Acronym TRIFECTA-SCC
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medical College of Wisconsin
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.